false 0001850767 0001850767 2024-06-17 2024-06-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): June 17, 2024

 

 

 

AccuStem Sciences Inc.

(Exact Name of Registrant as Specified in its Charter)

 

 

 

Delaware   000-56257   87-3774438

(State or Other Jurisdiction

of Incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

5 Penn Plaza, 19th Floor, #1954

New York, NY

  10001
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: 00 44 2074952379

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 4.01 Change in Registrant’s Certifying Accountant.

 

On June 17, 2024, Mercurius LLP (“Mercurius”) was appointed as Accustem Sciences, Inc.’s (the “Company”) independent registered public accounting firm.

 

During the years ended December 31, 2023 and 2022 and through June 17, 2024, the date the audit committee of the Board approved the engagement of Mercurius as the Company’s independent registered public accounting firm, neither the Company nor anyone on the Company’s behalf consulted with Mercurius regarding (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements, and no written report or oral advice was provided to the Company by the Company that the Company concluded was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issue; or (ii) any matter that was either the subject of a disagreement, as that term is described in Item 304(a)(1)(iv) of Regulation S-K under the Exchange Act, or a reportable event, as that term is defined in Item 304(a)(1)(v) of Regulation S-K under the Exchange Act.

 

-2-
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  ACCUSTEM SCIENCES INC.
     
Date: December 30, 2024 By: /s/ Wendy Blosser
    Wendy Blosser
    Chief Executive Officer

 

-3-

v3.24.4
Cover
Jun. 17, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jun. 17, 2024
Entity File Number 000-56257
Entity Registrant Name AccuStem Sciences Inc.
Entity Central Index Key 0001850767
Entity Tax Identification Number 87-3774438
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 5 Penn Plaza
Entity Address, Address Line Two 19th Floor
Entity Address, Address Line Three #1954
Entity Address, City or Town New York
Entity Address, State or Province NY
Entity Address, Postal Zip Code 10001
City Area Code 00 44
Local Phone Number 2074952379
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Accustem Sciences (QB) (USOTC:ACUT)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Accustem Sciences (QB) Charts.
Accustem Sciences (QB) (USOTC:ACUT)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Accustem Sciences (QB) Charts.